<?xml version="1.0" encoding="UTF-8"?>
<ref id="B11">
 <label>11.</label>
 <mixed-citation publication-type="book">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Tatara</surname>
    <given-names>A.M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ratcliffe</surname>
    <given-names>A.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wong</surname>
    <given-names>M.E.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kasper</surname>
    <given-names>F.K.</given-names>
   </name>, and 
   <name name-style="western">
    <surname>Mikos</surname>
    <given-names>A.G.</given-names>
   </name>
  </person-group> Biomaterials in regenerative medicine: considerations in early process development. In: Translational Regenerative Medicine. Elsevier, 2015, p. 141
 </mixed-citation>
</ref>
